Extra! Extra! Read All About It!

Mattel To Make ‘Bald Friend Of Barbie’

Mattel, the maker of Barbie, will produce a bald fashion doll for children who have lost their hair because of illness or cancer, the company announced today.

“These dolls, which will be a friend of Barbie, will be distributed exclusively to children’s hospitals and other hospitals treating children with cancer throughout the U.S. and Canada, directly reaching girls who are most affected by hair loss,” said Mattel Company spokesman Alan Hilowitz in a statement.

Read More: abcnews.go.com/blogs/health/2012/03/29/mattel-to-produce-bald-friend…

New York Times: Adrienne Rich, 1929-2012

“Adrienne Rich, a poet of towering reputation and towering rage, whose work — distinguished by an unswerving progressive vision and a dazzling, empathic ferocity — brought the oppression of women and lesbians to the forefront of poetic discourse and kept it there for nearly a half-century, died on Tuesday at her home in Santa Cruz, Calif. She was 82.

The cause was complications of rheumatoid arthritis, with which she had lived for most of her adult life, her family said.”

Read More: www.nytimes.com/2012/03/29/books/adrienne-rich-feminist-poet-and-author-dies-at-82.html

Clinical Pharmacology & Therapeutics: Current Understanding Of Rheumatoid Arthritis Therapy

“Progress in understanding the cellular and molecular mechanisms of rheumatoid arthritis (RA), together with the availability of new therapies, has changed the way we think about RA. The paradigm shift in RA therapy has been from controlling symptoms to controlling the disease process with the abrogation of inflammation. Challenges that are still unresolved include the issues in disease prevention, treatment specificity to restore tolerance, approaches to facilitate tissue repair, and treatment optimization to fit the individual patient’s disease phenotype and comorbidity context. This review summarizes the pathogenesis-related rationales for the current therapeutic strategies in RA and for emerging therapies and potential approaches to restoring immune tolerance in RA.”

Read More: http://www.nature.com/clpt/journal/v91/n4/full/clpt2011325a.html

The Press Association: Rheumatoid Arthritis Breakthrough

A drug that “blindfolds” white blood cells could provide a new way of treating rheumatoid arthritis, new research has shown.

The drug stops the destructive cells migrating to the joints, where they cause the typical damage associated with the disease.

Rheumatoid arthritis is an auto-immune disease in which elements of the immune system attack the body. White blood cells called T-cells are key players in the process.

Study leader Dr Graeme O’Boyle, from the University of Newcastle, said; “Imagine that the damaged joint is covered in flags which are signalling to the white blood cells. Traditional treatments have involved pulling down the flags one by one but what we have done is use an agent which in effect ‘blindfolds’ the white blood cells.

“Therefore, they don’t know which way to travel and so won’t add to the damage.”
The study, funded by the charity Arthritis Research UK, is published in the journal Proceedings of the National Academy of Sciences.

Read More: http://www.google.com/hostednews/ukpress/article/ALeqM5hu…

New York Times: Supply of Methotrexate May Run Out Within Weeks

“This is dire,” said Valerie Jensen, associate director of the Food and Drug Administration’s drug shortages program. “Supplies are just not meeting demand.”

The drug is methotrexate, and the cancer it treats is known as acute lymphoblastic leukemia, or A.L.L., which most often strikes children ages 2 to 5. It is an unusually virulent cancer of white blood cells that are overproduced in bone marrow and invade other parts of the body.

The cancer commonly spreads to the lining of the spine and brain, and oncologists prevent this by injecting large quantities of preservative-free methotrexate directly into the spinal fluid. The preservative can cause paralysis when injected into the spinal column, so cannot be used for this disease. Methotrexate is also used to treat rheumatoid arthritis.

Read More: http://www.nytimes.com/2012/02/11/health/policy/supply-of-methotrexate-a-cancer-drug-may-run-out-soon.html?_r=1